Trials / Conditions / Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

6 registered clinical trials studyying Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Stud NCT04900623	Jonathan Schoenfeld, MD, MPH	Phase 2
Completed	Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unkn NCT04489212	Mayo Clinic	N/A
Active Not Recruiting	De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patien NCT03952585	National Cancer Institute (NCI)	Phase 2 / Phase 3
Active Not Recruiting	Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squ NCT03799445	M.D. Anderson Cancer Center	Phase 2
Terminated	Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Par NCT03618134	Jonsson Comprehensive Cancer Center	Phase 1 / Phase 2
Recruiting	Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With NCT03010150	M.D. Anderson Cancer Center	—